期刊文献+

非甾体抗炎药的胃肠损害及其预防 被引量:15

NSAIDs-induced gastrointestinal injury and its prevention
原文传递
导出
摘要 非甾体抗炎药(NSAIDs)在临床上广泛用于风湿性疾病及心血管疾病的治疗。NSAIDs的常见不良反应为胃肠道不适、恶心,严重不良反应有消化性溃疡、胃肠道出血或穿孔。胃肠损伤发生的原因是由于NSAIDs抑制了环氧酶(COX)系统而阻断了前列腺素的合成,因此干扰了正常黏膜保护机制导致局部受损。NSAIDs致胃肠道损伤的危险因素为高龄、有消化性溃疡或出血史。预防NSAIDs所致胃肠损伤的措施有:应用预防溃疡的药物,选择新一代高选择性COX-2抑制剂,根据患者情况应用抗幽门螺杆菌疗法,依据患者相关的危险因素采用不同的治疗方案。 Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for treatment of rheumatic and cardiovascular diseases in clinical practice. The most common adverse reactions to NSAIDs are gastrointestinal discomfort, nausea, and severe reactions are peptic ulcer, gastrointestinal bleeding or perforation, The pathogenesis of gastrointestinal injury is that NSAIDs inhibit COX enzyme system, thus blocking the prostaglandin synthesis; in turn, interferes with normal mucosal protective mechanisms, leading to local injury, The risk factors for gastrointestinal injury induced by NSAIDs are old age, a history of peptic ulcers or bleeding of gastrointestinal tract, Ways of preventing NSAlDs-induced gastrointestinal injury include the use of ulcer-preventing drugs, the choice of new hlgh-selective COX-2 inhibitors, the use of anti-Hellcobacter pylori therapy according the patient's condition, and taking different therapeutic programs based on patient-related risk factors.
出处 《药物不良反应杂志》 2008年第3期190-194,共5页 Adverse Drug Reactions Journal
关键词 非甾体抗炎药 胃肠损伤 预防 NSAIDs gastrointestinal injury prevention
  • 相关文献

参考文献25

  • 1Rahme E, Joseph L, Kong SX, et al. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospeetive cohort study of an elderly population[ J ]. Arthritis Rheum, 2000, 43(4) : 917-924. 被引量:1
  • 2Vane J. Towards a better aspirin[ J] . Nature, 1994, 367 (6460) : 215-216. 被引量:1
  • 3Coruzzi G, Venturi N, Spaggiari S. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond [ J]. Acta Biomed, 2007, 78(2) : 96-110. 被引量:1
  • 4Brun J, Jones R. Non-steroidal anti-inflammatory drugassociatted dyspepsia: the scale of the problem[ J ]. Am J Med, 2001, 110(1A): 12S-13S. 被引量:1
  • 5Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration[J]. Gut ,1987, 28(5): 527-532. 被引量:1
  • 6Kimmey MB, Lanas A. Appropriate use of proton pump inhibitors with traditional nonsteroidal anti-inflammatory drugs and COX-2 selective inhibitors[ J]. Aliment Pharmacol Ther, 2004, 19(Suppl 1 ): 60-65. 被引量:1
  • 7Laine L, Bombardier C, Hawkey CJ, et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis [ J]. Gastroenterology, 2002, 123 (4): 1006-1012. 被引量:1
  • 8Goldstein JL. Challenges in managing NSAID-associated gastrointestinal tract injury [ J ]. Digestion, 2004, 69 ( Suppl 1 ) :25-33. 被引量:1
  • 9Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal antiinflammatory drugs. A randomized, double-blind, placebo-controlled trial[ J ]. Ann Intern Med, 1995, 123 (4) : 241-249. 被引量:1
  • 10McCathy DM. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of nonsteroidal anti-inflammatory drugs: what are the connections? [J]. Eur J Surg Suppl, 2002(587) :89-99. 被引量:1

同被引文献120

引证文献15

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部